These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34298122)

  • 1. Cigarette smoking induces aberrant N
    Jin M; Li G; Liu W; Wu X; Zhu J; Zhao D; Zeng Z; Xiong M; Song Y; He X; Zhang Q; Hu K
    Cancer Lett; 2021 Oct; 518():214-229. PubMed ID: 34298122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking, by accelerating the cell cycle, promotes the progression of non-small cell lung cancer through an HIF-1α-METTL3-m
    Yang Y; Cheng C; He B; Du X; Liu J; Xia H; Wang P; Wu M; Wu H; Liu Q
    J Hazard Mater; 2023 Aug; 455():131556. PubMed ID: 37156046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
    Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
    J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTSJ1 regulates tRNA 2'-O-methyladenosine modification and suppresses the malignancy of NSCLC via inhibiting DRAM1 expression.
    He Q; Yang L; Gao K; Ding P; Chen Q; Xiong J; Yang W; Song Y; Wang L; Wang Y; Ling L; Wu W; Yan J; Zou P; Chen Y; Zhai R
    Cell Death Dis; 2020 May; 11(5):348. PubMed ID: 32393790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VIRMA contributes to non-small cell lung cancer progression via N
    Xu Y; Chen Y; Yao Y; Xie H; Lu G; Du C; Cheng J; Zhou J
    Cancer Lett; 2021 Dec; 522():142-154. PubMed ID: 34520821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
    Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of m
    Wang J; Tan L; Jia B; Yu X; Yao R; OUYang N; Yu X; Cao X; Tong J; Chen T; Chen R; Li J
    Int J Biol Sci; 2021; 17(10):2633-2651. PubMed ID: 34326699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway.
    Xu L; Li K; Li J; Xu F; Liang S; Kong Y; Chen B
    Epigenetics; 2023 Dec; 18(1):2265625. PubMed ID: 37871286
    [No Abstract]   [Full Text] [Related]  

  • 9. N
    Zhu Z; Qian Q; Zhao X; Ma L; Chen P
    Gene; 2020 Mar; 731():144348. PubMed ID: 31927006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTO facilitates cancer metastasis by modifying the m
    Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
    Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDLIM2 acts as a cancer suppressor gene in non-small cell lung cancer via the down regulation of NF-κB signaling.
    Shi H; Ji Y; Li W; Zhong Y; Ming Z
    Mol Cell Probes; 2020 Oct; 53():101628. PubMed ID: 32621848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Id-1 promotes migration and invasion of non-small cell lung cancer cells through activating NF-κB signaling pathway.
    Li J; Li Y; Wang B; Ma Y; Chen P
    J Biomed Sci; 2017 Dec; 24(1):95. PubMed ID: 29233161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo.
    Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H
    Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling.
    Li Q; Jiang B; Qi Y; Zhang H; Ma H
    Cancer Biol Ther; 2020 Sep; 21(9):806-814. PubMed ID: 32687454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
    Huang RS; Zheng YL; Zhao J; Chun X
    Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of m
    Sun S; Han Q; Liang M; Zhang Q; Zhang J; Cao J
    Thorac Cancer; 2020 Nov; 11(11):3269-3279. PubMed ID: 32956555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway.
    Li Y; Deng L; Zhao X; Li B; Ren D; Yu L; Pan H; Gong Q; Song L; Zhou X; Dai T
    J Pathol; 2018 Nov; 246(3):366-378. PubMed ID: 30043491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM13 inhibited cell proliferation and induced cell apoptosis by regulating NF-κB pathway in non-small-cell lung carcinoma cells.
    Xu L; Wu Q; Zhou X; Wu Q; Fang M
    Gene; 2019 Oct; 715():144015. PubMed ID: 31357025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
    Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB-Induced Upregulation of miR-548as-3p Increases Invasion of NSCLC by Targeting PTEN.
    Akgun S; Kucuksayan H; Ozes ON; Can O; Alikanoglu AS; Yildiz M; Akca H
    Anticancer Agents Med Chem; 2019; 19(8):1058-1068. PubMed ID: 30727918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.